- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02170428
Diet and Well-being of Young Danish Children (SKOT I)
November 11, 2019 updated by: Arne Astrup, University of Copenhagen
The SKOT I Cohort - a Prospective Cohort Study of Diet and Well-being in Young Danish Children
The overall objective with the study was to contribute to the scientific basis for dietary and life strategies, policies and dietary guidelines to infants and young children in Denmark and with special focus on prevention of obesity and diet related chronic diseases such as type 2 diabetes, ischemic heart disease and osteoporosis.
Study Overview
Status
Completed
Detailed Description
The SKOT I study is a prospective cohort study monitoring healthy young children from 9 to 36 months of age.
In 2007, 2211 families from Copenhagen were randomly selected through the National Civil Registry and invited to participate in the study by letter.
The participants were invited to three examinations at 9 months ±2 weeks, 18 months ±4 weeks and 36 months ±3 months.
A total of 330 children are included in the study, where 312 have completed the 9 months examination, 291 completed the 18 months examination and 263 completed the 3-year examination.
All examinations took place at Department of Nutrition, Exercise and Sports, Frederiksberg Denmark.
The examinations involved collecting a broad spectrum of data.
Following data were collected: anthropometry (weight, height, age- and sex-specific Z-scores for body composition, triceps and subscapularis skinfolds), background interview (concerning e.g.
infant feeding, household income, the parent's educational level, allergy and chronic diseases), blood pressure (systolic, diastolic and mean arterial pressure), faeces- and urine sample, blood samples (9 and 36 months), Bio impedance analysis (36 months), 7 day diet registration, general questionaire (concerning e.g.
sleep, daycare, attendance and use of screen devices), psychomotor questionnaire (motoric development), 7 day physical activity monitoring and dual energy x-ray absorptiometry scan (36 months).
Study Type
Observational
Enrollment (Actual)
263
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Frederiksberg, Denmark, 1958
- Department of Human Nutrition, Faculty of Sciences, University of Copenhagen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
9 months to 3 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Healthy young Danish Children selected through the National Civil Registry and invited to participate by letter.
Description
Inclusion Criteria:
- healthy singletons born at term (week 37-43) between August 2006 and September 2007 with no disease that could influence food intake or growth
Exclusion Criteria:
- born preterm (before week 37)
- non-Danish speaking parents.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
growth and development
Growth and development of a random sample of healthy Danish infants
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in anthropometric measurements in periods of early childhood.
Time Frame: 9, 18 and 36 months of age
|
Composite outcome consisting of body weight, height, body mass index (BMI) and BMI z-scores, waist-, upper arm- and head circumference, skinfold thickness measured at subscapularis and triceps.
|
9, 18 and 36 months of age
|
|
Body composition in early childhood
Time Frame: 36 months of age
|
Body composition is measures by Dual-energy X-ray Absorptiometry and bio impedance.
Fat mass, fat mass index (kg/m2), fat free mass index (kg/m2) are calculated.
|
36 months of age
|
|
Metabolic syndrome score in early life
Time Frame: 9 and 36 months of age
|
Composite outcome consisting of triglycerides, high lipoprotein (HDL) and glucose measured in plasma/serum, waist circumference and blood pressure.
|
9 and 36 months of age
|
|
Diet in periods of early life
Time Frame: 9, 18 and 36 months of age
|
The diet is recorded using self-reported 7-day record questionnaire.
|
9, 18 and 36 months of age
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Breastfeeding duration in infancy and early childhood
Time Frame: 9, 18 and 36 months of age
|
Questionnaire used for assessment of exclusive and partially breastfeeding.
|
9, 18 and 36 months of age
|
|
Insulin like growth factor at 9 and 36 months of age
Time Frame: 9 and 36 months of age
|
Insulin like growth factor-1 and insulin like growth factor binding protein-3 concentrations in plasma.
|
9 and 36 months of age
|
|
Physical activity, sedentary behavior and sleep in early childhood
Time Frame: 9, 18 and 36 months of age
|
Physical activity and sedentary behavior measured by ActiGrafph GT3X accelerometer, recording for 24 hours in 7 days at 36 months of age.
Information on outdoor activity, sedentary behavior and night sleep are collected through questionnaires at 9, 18 and 36 months of age.
|
9, 18 and 36 months of age
|
|
Bone mass in 3-year-old children
Time Frame: 36 months of age
|
Bone mass is measured by Dual-energy X-ray Absorptiometry
|
36 months of age
|
|
Vitamin D status in infancy
Time Frame: 9 months of age
|
25-hydroxyvitamin D concentrations are analysed in blood samples at 9 months of age.
|
9 months of age
|
|
Allergy and chronic diseases
Time Frame: 9 and 36 months of age
|
Assessment of diseases by questionnaires
|
9 and 36 months of age
|
|
Appetite hormones in infancy
Time Frame: 9 months of age
|
Leptin and adiponectin concentrations measured from blood samples
|
9 months of age
|
|
Change in gut microbiota
Time Frame: 9, 18 and 36 months of age
|
Microbiota in the faeces analysed using polymerase chain reaction (PCR)
|
9, 18 and 36 months of age
|
|
Achievement of milestones
Time Frame: 9 and 36 months of age
|
Achievement of age-specific milestones by questionnaires; WHO questionnaires at 9 and 36 months of age and Ages & Stages Questionnaires (ASQ) at 36 months of age
|
9 and 36 months of age
|
|
Metabolomics in the urine
Time Frame: 9, 18 and 36 months of age
|
Metabolomics analysed using urine samples.
|
9, 18 and 36 months of age
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Kim F Michaelsen, MD Professor, Faculty of Science, University of Copenhagen
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2007
Primary Completion (Actual)
October 1, 2010
Study Completion (Actual)
October 1, 2010
Study Registration Dates
First Submitted
June 4, 2014
First Submitted That Met QC Criteria
June 17, 2014
First Posted (Estimate)
June 23, 2014
Study Record Updates
Last Update Posted (Actual)
November 13, 2019
Last Update Submitted That Met QC Criteria
November 11, 2019
Last Verified
November 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- D201
- H-KF-2007-0003 (Other Identifier: The Committees on Biomedical Research Ethics for the Capital Region of Denmark)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Growth Acceleration
-
University of California, DavisCompletedGrowth Acceleration | Growth RetardationUnited States
-
Société des Produits Nestlé (SPN)Completed
-
Bright Dairy & Food Co., LtdCompleted
-
Ethiopian Public Health InstituteWageningen University; Micronutrient InitiativeCompletedGrowth Acceleration | Infant MorbidityEthiopia
-
Ege UniversityBuca Women Birth and Child Diseases HospitalCompletedGrowth Acceleration | Development, Infant | Breastfeeding, Exclusive | AttachmentTurkey
-
University of CopenhagenUniversity of Aarhus; Arla FoodsCompletedGrowth Acceleration | Growth; Stunting, NutritionalDenmark
-
NEOCOSURUnknown
-
University of IcelandHarvard Medical School (HMS and HSDM); Massachusetts General Hospital; University...CompletedAdiposity | Body Composition, Beneficial | Growth Acceleration
-
Sana'a UniversityNot yet recruitingAcceleration of Tooth Movement
-
Kufa UniversityCompletedPhotobiomodulation Therapy | Orthodontic Treatment AccelerationIraq